OptimizeRx Q3 2026 Results: Net Income $1.2M, Up 53.4% YoY
For the three months ended September 30, 2026, OptimizeRx reported net revenue of $21.6 million and net income of $1.2 million, compared to $26.1 million and $0.8 million in the prior year period. While quarterly profitability improved, the company recorded a slight net loss of $3,000 for the nine-month period as revenues declined from $77.2 million to $62.0 million year-over-year.
- Key figure
- Net income $1.2M · +53.4% YoY